Henry Schein reported $13.6B of revenue over the trailing twelve months, +6.5% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $13.6B (to Q2 2026). Net income: $403M, trailing twelve months to Q2 2026. Free cash flow: $569M, trailing twelve months to Q2 2026. Operating margin: 5.0%, trailing twelve months to Q2 2026.

HSICHenry Schein

Healthcare

$84.03+23% 1Y

$84.03

$62.0352 weeks$90.86

HSIC as reported

Henry Schein reported $13.6B of revenue over the trailing twelve months, +6.5% on the year before. 11 reported series are charted on this page, each one as filed.

$13.6B

Revenue, trailing twelve months · to Q2 2026 · +6.5% against the twelve months before

Net income: $403M
Net income · +3.6% year on year · trailing twelve months to Q2 2026
Free cash flow: $569M
Free cash flow · +50% year on year · trailing twelve months to Q2 2026
Operating margin: 5.0%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for HSIC, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$13.6B	+6.5%	Q2 2026
Net income	$403M	+3.6%	Q2 2026
EPS	$3.43	+10%	Q2 2026
Gross margin	31%	n/a	Q2 2026
Operating margin	5.0%	n/a	Q2 2026
Net margin	3.0%	n/a	Q2 2026
ROE	12%	n/a	Q2 2026
ROA	3.5%	n/a	Q2 2026
ROIC	8.2%	n/a	Q2 2026
Free cash flow	$569M	+50%	Q2 2026
P/E	24.5	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.